Veterinary vaccines play vital role in improving the health of companion animals. They are also important for reducing viral diseases transmitted from animals to animals as well as animals to humans. These vaccines are categorized into various product types such as Attenuated Live Vaccine, Conjugate Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, DNA Vaccine, and Recombinant Vaccine.
The rise in product approval activities is the key driving factor which is expected to boost the global companion animal vaccine market growth. For instance, in May 2020, Merck & Co., Inc had launched new vaccine known as NOBIVAC Myxo-RHD PLUS vaccine which is used to decrease mortality due to common viral diseases in rabbits like myxomatosis and rabbit haemorrhagic disease (RHD).Furthermore, increase in mergers and acquisitions by key players will positively contribute the market growth. For instance, in July 2019, Elanco Animal Health Incorporated had announced acquisition or Aratana Therapeutics for development and commercialization of innovative therapeutics for dogs and cats. Moreover, rise in product launch activities is expected to fuel the global companion animal vaccine market growth. In addition to that, increase in initiatives from regulatory authorities for prevention of diseases like viral diseases in companion animal which may drive the market growth during this forecast period. For instance, as per the American Animal Hospital Association has commissioned a task force of veterinary experts for development of guidelines which will help veterinary teams to work with pet owners for treatment plans that will improve the quality of life of pets with cancer.
Increase in cost for storage of vaccines and inadequate reporting systems is major restraining factors for market growth which is expected to hamper the global companion animal vaccine market growth during this forecast timeline.
Global Companion Animal Vaccine Market is segmented into product type such as Conjugate Vaccine, Attenuated Live Vaccine, Inactivated Vaccine, Toxoid Vaccine, Subunit Vaccine, DNA Vaccine, and Recombinant Vaccine, by animal type such as Canine, Feline, Equine, and Others. Further, market is segmented into distribution channel such as Veterinary Hospitals, and Veterinary Research Institutes.
Also, Global Companion Animal Vaccine Market is segmented various regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Ceva, Merck & Co., Inc, Virbac, Zoetis Inc, Biogénesis Bagó, Ourofino Animal Health,and HIPRA
By Product Type Conjugate Vaccine Attenuated Live Vaccine Inactivated Vaccine Toxoid Vaccine Subunit Vaccine DNA Vaccine Recombinant Vaccine
By Animal Type Canine Feline Equine Others
By Distribution Channel Veterinary Hospitals Veterinary Research Institutes
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Companion Animal Vaccine Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Companion Animal Vaccine Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Companion Animal Vaccine Market Share Analysis, By Product Type
5.3 Global Companion Animal Vaccine Market Size and Forecast, By Product Type
5.3.1 Conjugate Vaccine
5.3.2. Attenuated Live Vaccine
5.3.3 Inactivated Vaccine
5.3.4 Toxoid Vaccine
5.3.5 Subunit Vaccine
5.3.6 DNA Vaccine
5.3.7 Recombinant Vaccine
6 Global Companion Animal Vaccine Market, By Animal Type
6.1 Y-o-Y Growth Comparison, By Animal Type
6.2 Global Companion Animal Vaccine Market Share Analysis, By Animal Type
6.3 Global Companion Animal Vaccine Market Size and Forecast, By Animal Type
6.3.1 Canine
6.3.2 Feline
6.3.3 Equine
6.3.4 Others
7 Global Companion Animal Vaccine Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Companion Animal Vaccine Market Share Analysis, By Distribution Channel
7.3 Global Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
7.3. 1 Veterinary Hospital
7.3.2. Veterinary Research Institution
8Global Companion Animal Vaccine Market, By Region
8.1 Global Companion Animal Vaccine Market Share Analysis, By Region
8.2 Global Companion Animal Vaccine Market Share Analysis, By Region
8.3 Global Companion Animal Vaccine Market Size and Forecast, By Region
9 North America Companion Animal Vaccine Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Companion Animal Vaccine Market Share Analysis, By Product Type
9.3 North America Companion Animal Vaccine Market Size and Forecast, By Animal Type
9.4 North America Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
9.5 North America Companion Animal Vaccine Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeCompanion Animal Vaccine Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Companion Animal Vaccine Market Share Analysis, By Product Type
10.3 Europe Companion Animal Vaccine Market Size and Forecast, By Animal Type
10.4 Europe Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
10.5 Europe Companion Animal Vaccine Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Companion Animal Vaccine Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Companion Animal Vaccine Market Share Analysis, By Product Type
11.3 Asia Pacific Companion Animal Vaccine Market Size and Forecast, By Animal Type
11.4 Asia Pacific Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Companion Animal Vaccine Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Companion Animal Vaccine Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Companion Animal Vaccine Market Share Analysis, By Product Type
12.3 Latin America Companion Animal Vaccine Market Size and Forecast, By Animal Type
12.4 Latin America Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
12.5 Latin America Companion Animal Vaccine Market Size and Forecast, Country
13Middle East Companion Animal Vaccine Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Companion Animal Vaccine Market Share Analysis, By Product Type
13.3 Middle East Companion Animal Vaccine Market Size and Forecast, By Animal Type
13.4 Middle East Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
13.5 Middle East Companion Animal Vaccine Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Boehringer Ingelheim GmbH
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Elanco Animal Health Incorporated
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Ceva
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Merck & Co., Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Virbac
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Zoetis Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Biogénesis Bagó
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Ourofino Animal Health
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 HIPRA
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
